vaccines
| 4 min read
Microbubble-based genetic medicines, pharma deals, trial misses, and more led the news this week.
| 3 min read
Researchers developed a highly tolerable oral antiviral against orthoparamyxoviruses like measles and human parainfluenza virus types 1 and 3.
| 4 min read
FDA approvals, pharma deals, and genetic testing advancements led the news this week.
| 4 min read
Legal battles, FDA setbacks, billion-dollar bets, and more led the news this week.
| 6 min read
A century after the first vaccine, tuberculosis still claims over a million lives a year, but promising research could change the story.
| 6 min read
Harnessing human-first models to accelerate drug discovery, improve safety, and capture the diversity of human biology.
| 2 min read
Trinity College Dublin researchers report a nasal vaccine that prevented infection and spread of pertussis in preclinical models.
Available on Demand
Explore innovative methods to enhance RNA purification efficiency and ensure scalable, high-quality RNA production.
| 4 min read
Two new FDA approvals and promising clinical trial results for drugs to treat diabetes and lung cancer, and more led the news this week.
| 4 min read
The Bethesda Declaration, a new RSV antibody for kids, amylin’s promising weight loss results, and more were industry’s need-to-know stories this week.
